• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DPubChem:一个用于定量构效关系建模和高通量虚拟筛选的网络工具。

DPubChem: a web tool for QSAR modeling and high-throughput virtual screening.

机构信息

Institute of Parasitology, McGill University, Montreal, QC, H9X 3V9, Canada.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 1L7, Canada.

出版信息

Sci Rep. 2018 Jun 14;8(1):9110. doi: 10.1038/s41598-018-27495-x.

DOI:10.1038/s41598-018-27495-x
PMID:29904147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6002400/
Abstract

High-throughput screening (HTS) performs the experimental testing of a large number of chemical compounds aiming to identify those active in the considered assay. Alternatively, faster and cheaper methods of large-scale virtual screening are performed computationally through quantitative structure-activity relationship (QSAR) models. However, the vast amount of available HTS heterogeneous data and the imbalanced ratio of active to inactive compounds in an assay make this a challenging problem. Although different QSAR models have been proposed, they have certain limitations, e.g., high false positive rates, complicated user interface, and limited utilization options. Therefore, we developed DPubChem, a novel web tool for deriving QSAR models that implement the state-of-the-art machine-learning techniques to enhance the precision of the models and enable efficient analyses of experiments from PubChem BioAssay database. DPubChem also has a simple interface that provides various options to users. DPubChem predicted active compounds for 300 datasets with an average geometric mean and F score of 76.68% and 76.53%, respectively. Furthermore, DPubChem builds interaction networks that highlight novel predicted links between chemical compounds and biological assays. Using such a network, DPubChem successfully suggested a novel drug for the Niemann-Pick type C disease. DPubChem is freely available at www.cbrc.kaust.edu.sa/dpubchem .

摘要

高通量筛选 (HTS) 对大量化合物进行实验测试,旨在鉴定在特定测定中具有活性的化合物。或者,可以通过定量构效关系 (QSAR) 模型在计算上进行更快、更便宜的大规模虚拟筛选方法。然而,可用的高通量筛选异构数据量巨大,以及测定中活性与非活性化合物的比例不平衡,这使得这成为一个具有挑战性的问题。尽管已经提出了不同的 QSAR 模型,但它们存在一定的局限性,例如,高假阳性率、复杂的用户界面和有限的利用选项。因此,我们开发了 DPubChem,这是一种用于推导 QSAR 模型的新型网络工具,它实现了最先进的机器学习技术,以提高模型的精度,并能够有效地分析来自 PubChem 生物测定数据库的实验。DPubChem 还具有简单的界面,为用户提供了各种选项。DPubChem 对 300 个数据集进行了预测,平均几何平均值和 F 分数分别为 76.68%和 76.53%。此外,DPubChem 构建了交互网络,突出了化合物和生物测定之间的新预测联系。通过使用这样的网络,DPubChem 成功地为尼曼-皮克 C 型疾病推荐了一种新型药物。DPubChem 可在 www.cbrc.kaust.edu.sa/dpubchem 免费获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/1138f0c5ec9f/41598_2018_27495_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/3aa2234d9479/41598_2018_27495_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/e58a95bbcfb4/41598_2018_27495_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/c745fd9947ff/41598_2018_27495_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/4bbf717d9fa8/41598_2018_27495_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/1138f0c5ec9f/41598_2018_27495_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/3aa2234d9479/41598_2018_27495_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/e58a95bbcfb4/41598_2018_27495_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/c745fd9947ff/41598_2018_27495_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/4bbf717d9fa8/41598_2018_27495_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2ac/6002400/1138f0c5ec9f/41598_2018_27495_Fig5_HTML.jpg

相似文献

1
DPubChem: a web tool for QSAR modeling and high-throughput virtual screening.DPubChem:一个用于定量构效关系建模和高通量虚拟筛选的网络工具。
Sci Rep. 2018 Jun 14;8(1):9110. doi: 10.1038/s41598-018-27495-x.
2
Cloud 3D-QSAR: a web tool for the development of quantitative structure-activity relationship models in drug discovery.云 3D-QSAR:用于药物发现中定量构效关系模型开发的网络工具。
Brief Bioinform. 2021 Jul 20;22(4). doi: 10.1093/bib/bbaa276.
3
Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.谱定量构效关系(Profile-QSAR):一种新型的元定量构效关系方法,它结合了激酶家族的各项活性,可准确预测亲和力、选择性和细胞活性。
J Chem Inf Model. 2011 Aug 22;51(8):1942-56. doi: 10.1021/ci1005004. Epub 2011 Jul 19.
4
Mining Chemical Activity Status from High-Throughput Screening Assays.从高通量筛选实验中挖掘化学活性状态
PLoS One. 2015 Dec 14;10(12):e0144426. doi: 10.1371/journal.pone.0144426. eCollection 2015.
5
QSAR modeling of imbalanced high-throughput screening data in PubChem.基于PubChem中不平衡高通量筛选数据的定量构效关系建模
J Chem Inf Model. 2014 Mar 24;54(3):705-12. doi: 10.1021/ci400737s. Epub 2014 Feb 28.
6
Bambu and its applications in the discovery of active molecules against melanoma.竹及其在发现抗黑色素瘤活性分子中的应用。
J Mol Graph Model. 2023 Nov;124:108564. doi: 10.1016/j.jmgm.2023.108564. Epub 2023 Jul 11.
7
DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learning.DRABAL:一种使用贝叶斯主动学习挖掘大型高通量筛选试验的新方法。
J Cheminform. 2016 Nov 10;8:64. doi: 10.1186/s13321-016-0177-8. eCollection 2016.
8
Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models.使用机器学习模型提高人激肽释放酶5抑制剂的虚拟筛选预测准确性。
Comput Biol Chem. 2017 Aug;69:110-119. doi: 10.1016/j.compbiolchem.2017.05.007. Epub 2017 May 29.
9
High-Throughput Screening Assay Profiling for Large Chemical Databases.高通量筛选测定大化学数据库。
Methods Mol Biol. 2022;2474:125-132. doi: 10.1007/978-1-0716-2213-1_12.
10
Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.通过定量构效关系和机器学习方法对来自雌激素受体测定的大量环境化学物质进行二元分类。
J Chem Inf Model. 2013 Dec 23;53(12):3244-61. doi: 10.1021/ci400527b. Epub 2013 Dec 11.

引用本文的文献

1
Drug Repurposing: Insights into Current Advances and Future Applications.药物再利用:当前进展与未来应用洞察
Curr Med Chem. 2025;32(3):468-510. doi: 10.2174/0109298673266470231023110841.
2
FP-MAP: an extensive library of fingerprint-based molecular activity prediction tools.FP-MAP:一个基于指纹的分子活性预测工具的丰富库。
Front Chem. 2023 Aug 15;11:1239467. doi: 10.3389/fchem.2023.1239467. eCollection 2023.
3
Leveraging Cell Painting Images to Expand the Applicability Domain and Actively Improve Deep Learning Quantitative Structure-Activity Relationship Models.

本文引用的文献

1
OmniGA: Optimized Omnivariate Decision Trees for Generalizable Classification Models.OmniGA:用于可推广分类模型的优化单变量决策树。
Sci Rep. 2017 Jun 20;7(1):3898. doi: 10.1038/s41598-017-04281-9.
2
AMMOS2: a web server for protein-ligand-water complexes refinement via molecular mechanics.AMMOS2:一个通过分子力学对蛋白质-配体-水复合物进行精修的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W350-W355. doi: 10.1093/nar/gkx397.
3
Chembench: A Publicly Accessible, Integrated Cheminformatics Portal.化学工作台:一个可公开访问的综合化学信息学门户。
利用细胞染色图像扩展适用范围并积极改进深度学习定量构效关系模型。
Chem Res Toxicol. 2023 Jul 17;36(7):1028-1036. doi: 10.1021/acs.chemrestox.2c00404. Epub 2023 Jun 16.
4
Application of Computational Biology and Artificial Intelligence in Drug Design.计算生物学和人工智能在药物设计中的应用。
Int J Mol Sci. 2022 Nov 5;23(21):13568. doi: 10.3390/ijms232113568.
5
Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands.无实际痛苦的收获:“公平试验策略”在多靶点配体开发中的地位。
Acta Pharm Sin B. 2021 Nov;11(11):3417-3432. doi: 10.1016/j.apsb.2021.02.023. Epub 2021 Mar 4.
6
Artificial intelligence to deep learning: machine intelligence approach for drug discovery.人工智能到深度学习:药物发现的机器智能方法。
Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3. Epub 2021 Apr 12.
7
Repositioning of 8565 Existing Drugs for COVID-19.8565种现有药物重新定位用于治疗新冠肺炎。
J Phys Chem Lett. 2020 Jul 2;11(13):5373-5382. doi: 10.1021/acs.jpclett.0c01579. Epub 2020 Jun 23.
8
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace.虚拟筛选网络服务器:在网络空间中设计化学探针和药物候选物。
Brief Bioinform. 2021 Mar 22;22(2):1790-1818. doi: 10.1093/bib/bbaa034.
9
The Roles of the NLRP3 Inflammasome in Neurodegenerative and Metabolic Diseases and in Relevant Advanced Therapeutic Interventions.NLRP3 炎性小体在神经退行性和代谢性疾病及相关先进治疗干预中的作用。
Genes (Basel). 2020 Jan 27;11(2):131. doi: 10.3390/genes11020131.
10
Machine and deep learning approaches for cancer drug repurposing.机器和深度学习方法在癌症药物再利用中的应用。
Semin Cancer Biol. 2021 Jan;68:132-142. doi: 10.1016/j.semcancer.2019.12.011. Epub 2020 Jan 3.
J Chem Inf Model. 2017 Feb 27;57(2):105-108. doi: 10.1021/acs.jcim.6b00462. Epub 2017 Jan 19.
4
DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learning.DRABAL:一种使用贝叶斯主动学习挖掘大型高通量筛选试验的新方法。
J Cheminform. 2016 Nov 10;8:64. doi: 10.1186/s13321-016-0177-8. eCollection 2016.
5
DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome.DPDR-CPI,一个通过化学-蛋白质相互作用组预测药物定位和药物重新定位的服务器。
Sci Rep. 2016 Nov 2;6:35996. doi: 10.1038/srep35996.
6
DASPfind: new efficient method to predict drug-target interactions.DASPfind:预测药物-靶点相互作用的新型高效方法。
J Cheminform. 2016 Mar 16;8:15. doi: 10.1186/s13321-016-0128-4. eCollection 2016.
7
Mining Chemical Activity Status from High-Throughput Screening Assays.从高通量筛选实验中挖掘化学活性状态
PLoS One. 2015 Dec 14;10(12):e0144426. doi: 10.1371/journal.pone.0144426. eCollection 2015.
8
STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data.STITCH 5:利用组织和亲和力数据扩充蛋白质-化学相互作用网络。
Nucleic Acids Res. 2016 Jan 4;44(D1):D380-4. doi: 10.1093/nar/gkv1277. Epub 2015 Nov 20.
9
A multi-label approach to target prediction taking ligand promiscuity into account.一种考虑配体混杂性的多标签靶标预测方法。
J Cheminform. 2015 May 30;7:24. doi: 10.1186/s13321-015-0071-9. eCollection 2015.
10
Deep learning.深度学习。
Nature. 2015 May 28;521(7553):436-44. doi: 10.1038/nature14539.